fig2
![MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy](https://image.oaes.cc/0f958f15-a9fe-4504-970f-db41e2c05fbd/3140.fig.2.jpg)
Figure 2. Dot plots illustrating the results from microRNA-126 (miRNA-126) A-C, and epidermal growth factor-like domain 7 (EGFL7) D-F analyses according to recurrence status, at baseline, operation, and follow-up, respectively. Horizontal bars represent medians